Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label, Single-Arm, Multicenter, Pharmacokinetic, Safety, and Efficacy Study of Adjunctive Administration of Brivaracetam in Subjects From ≥1 Month to <16 Years Old With Epilepsy

NCT00422422 is registered in ClinicalTrials.gov with UCB Pharma as lead sponsor.

NCT NCT00422422
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00422422 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label, Single-Arm, Multicenter, Pharmacokinetic, Safety, and Efficacy Study of Adjunctive Administration of Brivaracetam in Subjects From ≥1 Month to <16 Years Old With Epilepsy
Lead sponsor
UCB Pharma
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2011
Completion date
March 31, 2013
Enrollment
100 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy